CN103020778A - Standardized therapy management system used for hematological malignancy patients - Google Patents
Standardized therapy management system used for hematological malignancy patients Download PDFInfo
- Publication number
- CN103020778A CN103020778A CN2012105614547A CN201210561454A CN103020778A CN 103020778 A CN103020778 A CN 103020778A CN 2012105614547 A CN2012105614547 A CN 2012105614547A CN 201210561454 A CN201210561454 A CN 201210561454A CN 103020778 A CN103020778 A CN 103020778A
- Authority
- CN
- China
- Prior art keywords
- information
- patients
- module
- treatment
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A standardized therapy management system used for hematological malignancy patients comprises a data base, a recording module, an evaluation module and a statistics module. The standardized therapy management system used for hematological malignancy patients comprehensively records disease information of the patients; provides standardized therapy, evaluation procedure and examination and testing methods; and manages therapeutic evaluation time and reexamination time nodes of the patients in standardized mode. Doctors can improve the capability of clinician standardized therapy management through the statistics module, work omissions caused by inadequate experience and negligence can be reduced, and state, curative effect and prognoses of the hematological malignancy patients can be evaluated through the evaluation module.
Description
Technical field
The present invention relates to medical field, particularly a kind of disease treatment management system.
Background technology
Malignant hematologic disease comprises leukaemia, lymthoma, myeloma etc., has the characteristics such as treatment cycle is long, therapeutic scheme is complicated, the curative effect evaluation standard is various.On the one hand because disease itself needs the patient for a long time, repeatedly to return institute's treatment, on the other hand, owing to the going deep into of disease cognitive, need to the result for the treatment of of the past be had a kind of reasonable judgement.And the medical evaluation of present treatment of hematologic malignancies and curative effect, mainly depend on the summary of the own experience of doctor, most of clinicians place oneself in the midst of busy curative activity, the patients with malignant hematological diseases of being hospitalized for treatment is lacked comprehensive and systematic summary and evaluation, the impact of the speed of being updated one's knowledge in addition speed, some methods of treatments and prognostic evaluation standard lag significantly behind international treatment and progress in evaluation, cause the invalid evaluation of patient and over-treatment etc.
Traditional patient disease treatment management, the main patient of dependence simple papery version of the rear doctor case history of being admitted to hospital is first summed up, its deficiency is: lack systematicness and continuity 1.: the morbid state that the patient treatment the establishment of the project mainly is based on this when being admitted to hospital, to patient disease evolution understanding not, as changing doctor or hospital in the patient treatment process, the continuity for the treatment of and following up a case by regular visits to more can't guarantee; 2. different sick kind risks and therapeutic evaluation architectural difference are obvious: need the doctor to understand in detail the detailed content of each disease appraisement system, task is heavy; To evaluation time node and criterion of therapeutical effect may because of intelligential different occur uneven; 4. following up a case by regular visits to item and returning institute needs standardized management treatment time, avoids the some patients were concept of time not strong and inadequate to the disease attention degree, and causes the generation of severe complication and palindromia situation; 5. can't realize having access to and adding up of clinical valid data: the patient treatment relevant information is different because of different doctors' record custom in the clinical case history, the disappearance that can occur the disease assessment key message in the some cases, the electronic medical record system of clinical suitable row still can not effectively be had access to the valid data of malignant hematologic disease diagnosis, treatment and follow-up assessment at present.
Summary of the invention
Purpose of the present invention just provides a kind of Normalized Treatment management system for patients with malignant hematological diseases, it is convenient to comprehensive record patient information, standardization treatment, evaluation flow process and inspection, the method for inspection are provided, improve the ability of clinician's Normalized Treatment management, be beneficial to the assessment to the patients with malignant hematological diseases state of an illness, curative effect and prognosis.
The objective of the invention is to realize by such technical scheme, it includes database, and described system also includes logging modle, evaluation module and statistical module;
Logging modle is used for the input patient information, and is stored in the database; Patient information includes patient's morbidity process, classical symptom, sign, inspection check, repeatedly medicine for treatment scheme, bad reaction, complication, typical image collection, curative effect and the further consultation date; The HLA that patient information also includes patients with hematopoietic stem cells transplantation joins type result, pretreating scheme, bad reaction, complication, typical image collection, graft versus host disease(GVH disease), HVOD treatment, immunosuppressant scheme, the course for the treatment of and minimal residual disease detection information;
Evaluation module, according to the up-to-date international diagnosis of malignant hematologic disease, by stages, risk factor and curative effect evaluation standard, carry out data assessment according to the information of logging modle typing, and be stored in the database;
Statistical module is added up the information of logging modle typing and the information of evaluation module assessment, comprises patient's essential information, laboratory examination results, diagnostic message, therapeutic scheme and curative effect information, generates corresponding report, and is stored in the database.
Further, the information of described logging modle typing is by the manual typing of doctor.
Further, described system also includes user management module, and being used for administrative institute has user profile, and user profile includes clinician and patient's information.
Further, described system also includes system management module, call and revise management and notice time management for rights management, each module contents, the notice time management refers to disease feature and the therapeutic modality for different malignant hematologic diseases, notice patient treatment and check when treating, following up a case by regular visits at needs.
Owing to having adopted technique scheme, the present invention has advantages of as follows:
The present invention is by the illness information of the comprehensive record patient of logging modle, standardization treatment, evaluation flow process and inspection, the method for inspection are provided, standardized management patient therapeutic evaluation time and check timing node, the doctor can improve the ability of clinician's Normalized Treatment management by statistical module, reduce because lacking experience and neglecting the work careless omission that causes, by evaluation module the patients with malignant hematological diseases state of an illness, curative effect and prognosis are assessed.
Other advantages of the present invention, target and feature will be set forth to a certain extent in the following description, and to a certain extent, based on being apparent to those skilled in the art to investigating hereinafter, perhaps can be instructed from the practice of the present invention.Target of the present invention and other advantages can realize and obtain by following instructions and claims.
Description of drawings
Description of drawings of the present invention is as follows.
Fig. 1 is structural representation of the present invention.
Embodiment
The invention will be further described below in conjunction with drawings and Examples.
Be used for the Normalized Treatment management system of patients with malignant hematological diseases, include database, it is characterized in that: described system also includes logging modle, evaluation module and statistical module;
Logging modle is used for the input patient information, and is stored in the database; Patient information includes patient's morbidity process, classical symptom, sign, inspection check, repeatedly medicine for treatment scheme, bad reaction, complication, typical image collection, curative effect and the further consultation date; The HLA that patient information also includes patients with hematopoietic stem cells transplantation joins type result, pretreating scheme, bad reaction, complication, typical image collection, graft versus host disease(GVH disease), HVOD treatment, immunosuppressant scheme, the course for the treatment of and minimal residual disease detection information;
Evaluation module, according to the up-to-date international diagnosis of malignant hematologic disease, by stages, risk factor and curative effect evaluation standard, carry out data assessment according to the information of logging modle typing, and be stored in the database;
Statistical module is added up the information of logging modle typing and the information of evaluation module assessment, comprises patient's essential information, laboratory examination results, diagnostic message, therapeutic scheme and curative effect information, generates corresponding report, and is stored in the database.
The information of logging modle typing is by the manual typing of doctor.
System also includes user management module, and being used for administrative institute has user profile, and user profile includes clinician and patient's information.
System also includes system management module, call and revise management and notice time management for rights management, each module contents, the notice time management refers to disease feature and the therapeutic modality for different malignant hematologic diseases, notice patient treatment and check when treating, following up a case by regular visits at needs.
The present invention configures corresponding authority module information in system management, in user management, add after clinician's the data, the clinician can fill in associated conditions information by logging modle, includes clinical manifestation, diagnosis, laboratory examination, treatment situation, result for the treatment of, bad reaction, monitoring point, monitoring index and the Follow-up Data etc. of sufferer.The information completely of filling in comprised the needed information of state of an illness diagnosis, treatment, monitoring and assessment, then the doctor rationally judges by detailed information analysis, improve the ability of sequencing management, reduce because lacking experience and neglecting the work careless omission that causes, be beneficial to the assessment to the patients with malignant hematological diseases state of an illness and curative effect, rationally utilize medical resource, reduce the health financial burden of individual and society.
Explanation is at last, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although with reference to preferred embodiment the present invention is had been described in detail, those of ordinary skill in the art is to be understood that, can make amendment or be equal to replacement technical scheme of the present invention, and not breaking away from aim and the scope of the technical program, it all should be encompassed in the middle of the claim scope of the present invention.
Claims (4)
1. be used for the Normalized Treatment management system of patients with malignant hematological diseases, include database, it is characterized in that: described system also includes logging modle, evaluation module and statistical module;
Logging modle is used for the input patient information, and is stored in the database; Patient information includes patient's morbidity process, classical symptom, sign, inspection check, repeatedly medicine for treatment scheme, bad reaction, complication, typical image collection, curative effect and the further consultation date; The HLA that patient information also includes patients with hematopoietic stem cells transplantation joins type result, pretreating scheme, bad reaction, complication, typical image collection, graft versus host disease(GVH disease), HVOD treatment, immunosuppressant scheme, the course for the treatment of and minimal residual disease detection information;
Evaluation module, according to the up-to-date international diagnosis of malignant hematologic disease, by stages, risk factor and curative effect evaluation standard, carry out data assessment according to the information of logging modle typing, and be stored in the database;
Statistical module is added up the information of logging modle typing and the information of evaluation module assessment, comprises patient's essential information, laboratory examination results, diagnostic message, therapeutic scheme and curative effect information, generates corresponding report, and is stored in the database.
2. the Normalized Treatment management system for patients with malignant hematological diseases as claimed in claim 1, it is characterized in that: the information of described logging modle typing is by the manual typing of doctor.
3. the Normalized Treatment management system for patients with malignant hematological diseases as claimed in claim 1, it is characterized in that: described system also includes user management module, and being used for administrative institute has user profile, and user profile includes clinician and patient's information.
4. the Normalized Treatment management system for patients with malignant hematological diseases as claimed in claim 1, it is characterized in that: described system also includes system management module, call and revise management and notice time management for rights management, each module contents, the notice time management refers to disease feature and the therapeutic modality for different malignant hematologic diseases, notice patient treatment and check when treating, following up a case by regular visits at needs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105614547A CN103020778A (en) | 2012-12-21 | 2012-12-21 | Standardized therapy management system used for hematological malignancy patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105614547A CN103020778A (en) | 2012-12-21 | 2012-12-21 | Standardized therapy management system used for hematological malignancy patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103020778A true CN103020778A (en) | 2013-04-03 |
Family
ID=47969360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105614547A Pending CN103020778A (en) | 2012-12-21 | 2012-12-21 | Standardized therapy management system used for hematological malignancy patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103020778A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105956378A (en) * | 2016-04-26 | 2016-09-21 | 成都聚恒康科技有限公司 | Clinical decision supporting system of tumor diagnosis and treatment |
| CN110164551A (en) * | 2019-05-24 | 2019-08-23 | 山东大学齐鲁医院 | Blood disease intelligence diagnosis and treatment auxiliary system |
| CN112562810A (en) * | 2020-12-15 | 2021-03-26 | 张丽 | Plasma cell tumor disease management recording system and recording method |
| CN113658682A (en) * | 2021-07-29 | 2021-11-16 | 上海市第六人民医院 | Psoriasis and psoriatic arthritis follow-up management system |
| CN114025253A (en) * | 2021-11-05 | 2022-02-08 | 杭州联众医疗科技股份有限公司 | Drug efficacy evaluation system based on real world research |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080045811A1 (en) * | 1997-03-13 | 2008-02-21 | Clinical Decision Support, Llc | Disease management system and method including significant symptom filtering |
| CN102567646A (en) * | 2012-01-16 | 2012-07-11 | 中国人民解放军第三军医大学第二附属医院 | Self-management system used for patient with chronic airway disease |
| CN202331458U (en) * | 2011-06-03 | 2012-07-11 | 首都医科大学附属北京朝阳医院 | National malignant tumor interventional treatment registration system |
| CN102737165A (en) * | 2012-06-07 | 2012-10-17 | 北京太元通软件科技有限公司 | Clinical medication decision support system |
-
2012
- 2012-12-21 CN CN2012105614547A patent/CN103020778A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080045811A1 (en) * | 1997-03-13 | 2008-02-21 | Clinical Decision Support, Llc | Disease management system and method including significant symptom filtering |
| CN202331458U (en) * | 2011-06-03 | 2012-07-11 | 首都医科大学附属北京朝阳医院 | National malignant tumor interventional treatment registration system |
| CN102567646A (en) * | 2012-01-16 | 2012-07-11 | 中国人民解放军第三军医大学第二附属医院 | Self-management system used for patient with chronic airway disease |
| CN102737165A (en) * | 2012-06-07 | 2012-10-17 | 北京太元通软件科技有限公司 | Clinical medication decision support system |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105956378A (en) * | 2016-04-26 | 2016-09-21 | 成都聚恒康科技有限公司 | Clinical decision supporting system of tumor diagnosis and treatment |
| CN110164551A (en) * | 2019-05-24 | 2019-08-23 | 山东大学齐鲁医院 | Blood disease intelligence diagnosis and treatment auxiliary system |
| CN112562810A (en) * | 2020-12-15 | 2021-03-26 | 张丽 | Plasma cell tumor disease management recording system and recording method |
| CN113658682A (en) * | 2021-07-29 | 2021-11-16 | 上海市第六人民医院 | Psoriasis and psoriatic arthritis follow-up management system |
| CN114025253A (en) * | 2021-11-05 | 2022-02-08 | 杭州联众医疗科技股份有限公司 | Drug efficacy evaluation system based on real world research |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records | |
| Hong et al. | Big data in health care: Applications and challenges | |
| Meghani et al. | The conceptualization and measurement of comorbidity: a review of the interprofessional discourse | |
| JP2016519806A (en) | System and method for a personalized clinical decision support tool | |
| Benkner et al. | @ neurIST: infrastructure for advanced disease management through integration of heterogeneous data, computing, and complex processing services | |
| CN103020778A (en) | Standardized therapy management system used for hematological malignancy patients | |
| Johansen et al. | Value-based care in the worldwide battle against cancer | |
| Vedanthan et al. | Hypertension treatment rates and health care worker density: an analysis of worldwide data | |
| Lopetegui et al. | Inter-observer reliability assessments in time motion studies: the foundation for meaningful clinical workflow analysis | |
| Khoury et al. | Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine | |
| Su et al. | Mobilizing artificial intelligence to cardiac telerehabilitation | |
| Shahrokni et al. | Toward modernization of geriatric oncology by digital health technologies | |
| Frontoni et al. | A decision support system for diabetes chronic care models based on general practitioner engagement and EHR data sharing | |
| Mitchell | Internet of things-enabled smart devices, healthcare body sensor networks, and online patient engagement in COVID-19 prevention, screening, and treatment | |
| Ahmed | Intelligent health system for the investigation of consenting COVID-19 patients and precision medicine | |
| Jonas et al. | Proposal for an integrated evaluation model for the study of whole systems health care in cancer | |
| Chavda et al. | Artificial intelligence and machine learning in healthcare sector | |
| Yang et al. | The effect of electronic medical record application on the length of stay in a Chinese general hospital: a department-and disease-focused interrupted time-series study | |
| Mathkor et al. | Multirole of the Internet of Medical Things (IoMT) in Biomedical Systems for Managing Smart Healthcare Systems: An Overview of Current and Future Innovative Trends | |
| Weiner et al. | Electronic health records: high-quality electronic data for higher-quality clinical research. | |
| NandhaKumar et al. | A Survey on E-Health Care for Diabetes Using Cloud Framework | |
| Oluwagbemi et al. | A knowledge-based data mining system for diagnosing malaria related cases in healthcare management | |
| Malhotra et al. | Sequential pattern mining of electronic healthcare reimbursement claims: Experiences and challenges in uncovering how patients are treated by physicians | |
| Li et al. | Data mining analysis of inpatient fees in hospital information system | |
| Zhang | Big Data for Healthcare in China: a Review of the State-of-art |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130403 |